✦ LIBER ✦

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

✍ Scribed by Johan Wiström; Clas Ahlm; Sonia Lundberg; Bo Settergren; Arne Tärnvik

Book ID: 117433308
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 104 KB
Volume: 17
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(99)00012-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody persistence and the effect of a

Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine

✍ Vladimir Gilca; Gaston De Serres; Nicole Boulianne; Donald Murphy; Philippe De W 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs

Response to Hepatitis A Vaccine in Child

Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months Later

✍ Jorge Andrés Findor; María Cristina Cañero Velasco; Jorge Mutti; Assad Safary 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

Intradermal hepatitis B vaccination in a

Intradermal hepatitis B vaccination in a 300-bed primary care hospital: Experience with a recombinant vaccine in a four-dose schedule

✍ Kitt R. McMaster III; Judy K. Roper; John B. Carter 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 715 KB

Persistence of immunity and seroprotecti

Persistence of immunity and seroprotection 4 years after a primary vaccination schedule with a Hansenula polymorpha recombinant hepatitis B vaccine

✍ A Lepetic; C Biscayart; M Seigelchifer; R Arduino; D Stamboulian 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Long-term persistence of anti-HBs after

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

✍ Koen Van Herck; Pierre Van Damme; Stefan Thoelen; André Meheus 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 405 KB